David Good

David Good is a seasoned professional in business development and scientific research, currently serving as the Senior Director of Business Development at Aliri since March 2024 and as an Advisory Board Member at Immuto Scientific since December 2021. Previously, David held the position of Director of Business Development at BioAgilytix and was a Senior Pricing Manager at Labcorp Drug Development, where contributions spanned global pricing strategies across drug development phases. David's extensive experience also includes leadership roles at Covance, focusing on large biomolecule analysis and method development in mass spectrometry. An accomplished academic, David earned a Ph.D. in Analytical Chemistry from the University of Wisconsin-Madison, complemented by post-doctoral studies in Oncology and Cancer Biology and Bioanalytical Chemistry.